Anondita Medicare Ltd
Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.”[1]
- Market Cap ₹ 1,995 Cr.
- Current Price ₹ 1,103
- High / Low ₹ 1,227 / 262
- Stock P/E 59.6
- Book Value ₹ 71.5
- Dividend Yield 0.00 %
- ROCE 43.6 %
- ROE 40.0 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 15.4 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Personal Products Personal Care
Part of Nifty SME Emerge
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| 77 | 137 | |
| 51 | 87 | |
| Operating Profit | 26 | 51 |
| OPM % | 33% | 37% |
| 0 | 1 | |
| Interest | 3 | 4 |
| Depreciation | 1 | 1 |
| Profit before tax | 22 | 47 |
| Tax % | 25% | 27% |
| 16 | 34 | |
| EPS in Rs | 11.88 | 18.49 |
| Dividend Payout % | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 78% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 112% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 40% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 13 | 18 |
| Reserves | 25 | 111 |
| 27 | 34 | |
| 13 | 22 | |
| Total Liabilities | 78 | 185 |
| 14 | 84 | |
| CWIP | 6 | 0 |
| Investments | 3 | 0 |
| 55 | 101 | |
| Total Assets | 78 | 185 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| -10 | 11 | |
| -23 | -63 | |
| 33 | 61 | |
| Net Cash Flow | -0 | 9 |
| Free Cash Flow | -30 | -52 |
| CFO/OP | -38% | 28% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 127 | 138 |
| Inventory Days | 141 | 126 |
| Days Payable | 40 | 49 |
| Cash Conversion Cycle | 228 | 215 |
| Working Capital Days | 129 | 163 |
| ROCE % | 44% |
Insights
In beta| Jan 2026 | Mar 2027 (P) | |
|---|---|---|
| Installed Manufacturing Capacity million pieces per annum ・Standalone data |
|
|
| Capacity Under Trial Production million pieces per annum ・Standalone data |
||
| Existing Capacity Utilization million pieces per annum ・Standalone data |
||
| Existing Capacity Utilization (%) % ・Standalone data |
||
| IPO Proceeds Re-allocation to Working Capital INR Lakhs ・Standalone data |
||
| IPO Proceeds Utilized (Total) INR Lakhs ・Standalone data |
||
| IPO Unutilized Amount INR Lakhs ・Standalone data |
||
| L1 GeM Tender Supply Volume (Condoms) pieces ・Standalone data |
||
| L1 GeM Tender Supply Volume (Family Planning Items) pieces ・Standalone data |
||
| Order Value (CMSS GeM Tender) INR ・Standalone data |
||
| Projected Turnover for FY2025-26 INR Crores ・Standalone data |
||
| Target Capacity Expansion (Noida Facility) million pieces per annum ・Standalone data |
||
Extracted by Screener AI
Documents
Announcements
-
Corrigendum
23 May 2026 - Second corrigendum to 28 May 2026 EGM notice revises valuation report and PCS certificate for preferential issue at ₹1,038.
-
Integrated Filing- Financial
22 May 2026 - Anondita Medicare reported FY26 audited consolidated revenue of 13,741.57 lakh and net profit of 3,429.65 lakh.
-
Outcome of Board Meeting
22 May 2026 - Anondita Medicare announced audited standalone and consolidated results for year ended March 31, 2026.
-
Updates
22 May 2026 - Board approved audited FY2026 results; standalone revenue rose to Rs 11,160.62 lakh, profit to Rs 2,682.07 lakh.
-
Statement of deviation(s) or variation(s) under Reg. 32
22 May 2026 - Anondita Medicare Limited has informed about statement of deviation(s) or variation(s) under Reg. 32
Annual reports
No data available.
Concalls
-
Mar 2026TranscriptAI SummaryPPT
Business Profile:[1]
Anondita Medicare manufactures male (and recently, female) condoms, flagship brand “COBRA,” with in-house printing/packaging and 100% electronic testing.